Thomas Melendy
Impact in
- Oncology top 5%
- Polyomavirus and related diseases
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- DNA Repair Mechanisms
- Genomics and Chromatin Dynamics
- Cancer therapeutics and mechanisms
- DNA and Nucleic Acid Chemistry
Papers in
- Oncology 21
- Polyomavirus and related diseases 11
- Cancer-related Molecular Pathways 9
-
- DNA Repair Mechanisms 27
- Cancer therapeutics and mechanisms 13
- DNA and Nucleic Acid Chemistry 7
- Co-authors
- Bruce StillmanToshiki TsurimotoJacques ArchambaultDan S. RayYueh–Ming LooChristian T. ShelineD S RayИван Тодоров
- Journals
- Journal of Virology (9 papers)Virology (5 papers)Journal of Biological Chemistry (4 papers)Biochemistry (4 papers)Molecular and Cellular Biology (2 papers)
- Partner nations
- United StatesCanadaSaudi Arabia
In The Last Decade
Thomas Melendy
50 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 90
- Oncology 709
- Molecular Biology 1.7k
- Epidemiology 759
- Genetics 550
- Otorhinolaryngology 63
Countries citing papers authored by Thomas Melendy
This map shows the geographic impact of Thomas Melendy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Melendy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Melendy more than expected).
Fields of papers citing papers by Thomas Melendy
This network shows the impact of papers produced by Thomas Melendy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Melendy. The network helps show where Thomas Melendy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Melendy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 15 | |
| 5 | 2021 | 12 | |
| 6 | 2021 | 8 | |
| 7 | 2013 | 173 | |
| 8 | 2010 | 33 | |
| 9 | 2009 | 73 | |
| 10 | 2007 | 39 | |
| 11 | 2006 | 15 | |
| 12 | 2006 | 25 | |
| 13 | 2006 | 20 | |
| 14 | 2001 | 15 | |
| 15 | 2000 | 41 | |
| 16 | 1999 | 150 | |
| 17 | 1996 | 73 | |
| 18 | 1993 | 5 | |
| 19 | 1990 | 378 | |
| 20 | 1988 | 140 |
About Thomas Melendy
Thomas Melendy is a scholar working on Oncology, Molecular Biology, Cancer Research, Genetics and Epidemiology, having authored 51 papers that have together received 2.4k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (27 papers), Cancer therapeutics and mechanisms (13 papers), Polyomavirus and related diseases (11 papers), Cancer-related Molecular Pathways (9 papers), Virus-based gene therapy research (7 papers), Cervical Cancer and HPV Research (7 papers), DNA and Nucleic Acid Chemistry (7 papers) and Carcinogens and Genotoxicity Assessment (4 papers). The work is most often cited by research in Oncology (709 citations), Molecular Biology (1.7k citations), Epidemiology (759 citations), Genetics (550 citations) and Otorhinolaryngology (63 citations). Thomas Melendy has collaborated with scholars based in United States, Canada and Saudi Arabia. Frequent co-authors include Bruce Stillman, Toshiki Tsurimoto, Jacques Archambault, Dan S. Ray, Yueh–Ming Loo, Christian T. Sheline, D S Ray, Иван Тодоров, David M. Gilbert and Daniela S. Dimitrova. Their work appears in journals such as Journal of Virology, Virology, Journal of Biological Chemistry, Biochemistry and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.